Overseas Headlines – November 29, 2024

November 29, 2024

 

United States:

US Futures Gain as Dollar Snaps 8-Week Winning Run: Markets Wrap

 

US equity futures gained with Treasuries Friday, while speculation that president-elect Donald Trump will temper his most extreme trade policies drove the dollar to its biggest weekly loss in three months.

 

Contracts on the S&P 500 rose 0.2%, pointing to modest gains in Friday’s shortened, post-holiday trading session Wall Street. The 10-year Treasury yield fell five basis points to 4.21%, the lowest in more than a month, as cash trading resumed after the Thanksgiving holiday.

 

https://www.bloomberg.com/news/articles/2024-11-28/asian-stocks-to-slip-as-treasury-trading-resumes-markets-wrap?srnd=phx-markets

 

Europe:

Euro-Zone Inflation Accelerates But Won’t Derail ECB Cuts

 

Euro-area inflation climbed above the European Central Bank’s 2% target, though officials are unlikely to be deterred from continuing to lower interest rates next month and beyond.

 

Consumer prices rose 2.3% from a year ago in November, up from 2% in October and matching the median estimate in a Bloomberg survey of analysts.

 

https://www.bloomberg.com/news/articles/2024-11-29/euro-zone-inflation-accelerates-but-won-t-derail-ecb-rate-cuts

 

Asia:

PBOC Injects $111 Billion of Liquidity as Bond Supply Surges

 

China boosted its cash injection into the banking system via a recently launched policy tool, in a move designed to ensure sufficient liquidity amid a surge in local government bond sales.

 

The People’s Bank of China conducted 800 billion yuan ($111 billion) of outright reverse repurchase agreements in November, according to a statement Friday, exceeding the 500 billion yuan injected last month.

 

https://www.bloomberg.com/news/articles/2024-11-29/pboc-injects-111-billion-of-liquidity-as-bond-supply-surges

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

2024-11-29T08:52:49-05:00